These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19054548)

  • 1. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
    Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.
    Xie D; Ma NF; Pan ZZ; Wu HX; Liu YD; Wu GQ; Kung HF; Guan XY
    Hum Pathol; 2008 Jan; 39(1):80-6. PubMed ID: 17949776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic role of eIF-5A2 in the development of ovarian cancer.
    Guan XY; Fung JM; Ma NF; Lau SH; Tai LS; Xie D; Zhang Y; Hu L; Wu QL; Fang Y; Sham JS
    Cancer Res; 2004 Jun; 64(12):4197-200. PubMed ID: 15205331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
    Xie D; Lau SH; Sham JS; Wu QL; Fang Y; Liang LZ; Che LH; Zeng YX; Guan XY
    Cancer; 2005 Jan; 103(2):277-83. PubMed ID: 15578711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
    Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
    Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
    Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
    Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK
    Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.
    Guan XY; Sham JS; Tang TC; Fang Y; Huo KK; Yang JM
    Cancer Res; 2001 May; 61(9):3806-9. PubMed ID: 11325856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
    Farley J; Smith LM; Darcy KM; Sobel E; O'Connor D; Henderson B; Morrison LE; Birrer MJ;
    Cancer Res; 2003 Mar; 63(6):1235-41. PubMed ID: 12649182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
    Noske A; Lindenberg JL; Darb-Esfahani S; Weichert W; Buckendahl AC; Röske A; Sehouli J; Dietel M; Denkert C
    Oncol Rep; 2008 Dec; 20(6):1409-17. PubMed ID: 19020722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma.
    Mano MS; Awada A; Di Leo A; Durbecq V; Paesmans M; Cardoso F; Larsimont D; Piccart M
    Gynecol Oncol; 2004 Mar; 92(3):887-95. PubMed ID: 14984957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
    Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
    J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.